shares
question: Allergan is paying for Kythera Biopharmaceuticals in cash and what?, context: Allergan, the maker of Botox, said on Wednesday that it would pay about $2.1 billion in cash and shares for Kythera Biopharmaceuticals, which makes a treatment for double chins.
Allergan is paying for Kythera Biopharmaceuticals in cash and what?
Allergan, the maker of Botox, said on Wednesday that it would pay about $2.1 billion in cash and shares for Kythera Biopharmaceuticals, which makes a treatment for double chins.
Allergan, the maker of Botox, said on Wednesday that it would pay about $2.1 billion in cash and shares for Kythera Biopharmaceuticals, which makes a treatment for double chins.
Allergan, the maker of Botox, said on Wednesday that it would pay about $2.1 billion in cash and <hl> shares <hl> for Kythera Biopharmaceuticals, which makes a treatment for double chins.
Allergan, the maker of Botox, said on Wednesday that it would pay about $2.1 billion in cash and <hl> shares <hl> for Kythera Biopharmaceuticals, which makes a treatment for double chins.
<hl> Allergan, the maker of Botox, said on Wednesday that it would pay about $2.1 billion in cash and shares for Kythera Biopharmaceuticals, which makes a treatment for double chins. <hl>